Joseph Levy Foundation

The Joseph Levy Foundation, an independent family-led charity established in 1965 by Joseph Levy CBE BEM, supports ambitious organisations and individuals helping disadvantaged young people under 35 thrive amid health challenges, systemic inequalities, and social barriers. Rooted in the Levy family's personal connection to cystic fibrosis, its evolved 2025–2030 strategy emphasises equity, innovation, long-term partnerships, and person-centred systemic change, prioritising unrestricted core funding for trusted partners to tackle root causes of disadvantage.

It funds children's and young people's health (especially cystic fibrosis, autism, and chronic conditions), mental health, social mobility, inclusion, learning disabilities, leadership, arts, sport, and community initiatives for marginalised groups like disabled youth, ethnic minorities, and refugees. Grants support national charities (e.g., Cystic Fibrosis Trust, Ambitious about Autism) and grassroots efforts (e.g., Manchester Refugee Support Network), with named funds like the Joseph Levy Education Fund, primarily across the UK (England, Scotland, Wales, Northern Ireland) and occasionally Israel’s Jewish community.

Eligible applicants are UK-registered charities or community groups of any size or income, with no geographic base restriction, focusing on those demonstrating robust safeguarding, financial management, and direct impact on disadvantaged youth; no religious limits apply. Invitation-only applications follow proactive outreach, with trustees deciding quarterly—no public deadlines or unsolicited submissions—requiring flexible, low-burden case-by-case documentation.

Typical grants range £10,000–£25,000 annually (up to £300,000 total yearly), favouring multi-year core, project, or capacity-building support. Distinctive for its relational ethos, family governance, "common-sense reporting," and rejection of open rounds, it avoids non-youth-focused work, shunning short-term or misaligned efforts to foster enduring, equitable impact.